Cargando…

Reduced neutrophil elastase inhibitor elafin and elevated transforming growth factor-β(1) are linked to inflammatory response in sputum of cystic fibrosis patients with Pseudomonas aeruginosa

RESEARCH QUESTION: Pulmonary disease progression in patients with cystic fibrosis (CF) is characterised by inflammation and fibrosis and aggravated by Pseudomonas aeruginosa (Pa). We investigated the impact of Pa specifically on: 1) protease/antiprotease balance; 2) inflammation; and 3) the link of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Thomassen, Jan C., Trojan, Tobias, Walz, Maxine, Vohlen, Christina, Fink, Gregor, Rietschel, Ernst, Alejandre Alcazar, Miguel A., van Koningsbruggen-Rietschel, Silke
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Respiratory Society 2021
Materias:	Original Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8287132/ https://www.ncbi.nlm.nih.gov/pubmed/34291109 http://dx.doi.org/10.1183/23120541.00636-2020

Ejemplares similares

The effect of TGF-β(1) polymorphisms on pulmonary disease progression in patients with cystic fibrosis
por: Trojan, T., et al.
Publicado: (2022)

Getting Near to “Closing the Gap” in the Pediatric Age Group for the First Personalized Treatment of Cystic Fibrosis
por: van Koningsbruggen-Rietschel, Silke
Publicado: (2021)

Identification of Critical Windows of Metabolic Programming of Metabolism and Lung Function in Male Offspring of Obese Dams
por: Dinger, Katharina, et al.
Publicado: (2020)

Sputum and Plasma Neutrophil Elastase in Stable Adult Patients With Cystic Fibrosis in Relation to Chronic Pseudomonas Aeruginosa Colonization
por: AbdulWahab, Atqah, et al.
Publicado: (2021)

Elafin, an inhibitor of elastase, is a prognostic indicator in breast cancer
por: Hunt, Kelly K, et al.
Publicado: (2013)

Early-onset obesity dysregulates pulmonary adipocytokine/insulin signaling and induces asthma-like disease in mice
por: Dinger, Katharina, et al.
Publicado: (2016)

From the infant to the geriatric patient—Strategies for inhalation therapy in asthma and chronic obstructive pulmonary disease
por: Hagmeyer, Lars, et al.
Publicado: (2023)

Severe Pulmonary Arterial Hypertension Is Characterized by Increased Neutrophil Elastase and Relative Elafin Deficiency
por: Sweatt, Andrew J., et al.
Publicado: (2021)

Plasma Neutrophil Elastase and Elafin Imbalance Is Associated with Acute Respiratory Distress Syndrome (ARDS) Development
por: Wang, Zhaoxi, et al.
Publicado: (2009)

Sputum Active Polymyxin Lipopeptides: Activity against Cystic Fibrosis Pseudomonas aeruginosa Isolates and Their Interactions with Sputum Biomolecules
por: Schneider-Futschik, Elena K., et al.
Publicado: (2018)

Structural and antimicrobial properties of human pre-elafin/trappin-2 and derived peptides against Pseudomonas aeruginosa
por: Bellemare, Audrey, et al.
Publicado: (2010)

Impact of COVID-19 on people with cystic fibrosis
por: Colombo, Carla, et al.
Publicado: (2020)

The Serine Protease Inhibitor Elafin Maintains Normal Growth Control by Opposing the Mitogenic Effects of Neutrophil Elastase
por: Caruso, Joseph A., et al.
Publicado: (2014)

Diabetes in Cystic Fibrosis: Multicenter Screening Results Based on Current Guidelines
por: Scheuing, Nicole, et al.
Publicado: (2013)

IL-6-elafin genetically modified macrophages as a lung immunotherapeutic strategy against Pseudomonas aeruginosa infections
por: Kheir, Saadé, et al.
Publicado: (2022)

Neutrophil Elastase Enhances Sputum Solubilization in Cystic Fibrosis Patients Receiving DNase Therapy
por: Papayannopoulos, Venizelos, et al.
Publicado: (2011)

Draft Genome Sequences of 63 Pseudomonas aeruginosa Isolates Recovered from Cystic Fibrosis Sputum
por: Spilker, Theodore, et al.
Publicado: (2016)

Catabolism of Nucleic Acids by a Cystic Fibrosis Pseudomonas aeruginosa Isolate: An Adaptive Pathway to Cystic Fibrosis Sputum Environment
por: Kumar, Sheemal Shanista, et al.
Publicado: (2019)

Higher levels of Pseudomonas aeruginosa LasB elastase expression are associated with early-stage infection in cystic fibrosis patients
por: Llanos, Agustina, et al.
Publicado: (2023)

Nitrous Oxide Production in Sputum from Cystic Fibrosis Patients with Chronic Pseudomonas aeruginosa Lung Infection
por: Kolpen, Mette, et al.
Publicado: (2014)

435: Investigating the effect of host- and microbe-mediated zinc chelation on Pseudomonas aeruginosa in cystic fibrosis sputum
por: Vermilyea, D., et al.
Publicado: (2021)

Pseudomonas aeruginosa aggregation and Psl expression in sputum is associated with antibiotic eradication failure in children with cystic fibrosis
por: Morris, Amanda J., et al.
Publicado: (2022)

Evolutionary diversification of Pseudomonas aeruginosa in an artificial sputum model
por: Davies, Emily V., et al.
Publicado: (2017)

Activity of Delafloxacin and Comparator Fluoroquinolones against Multidrug-Resistant Pseudomonas aeruginosa in an In Vitro Cystic Fibrosis Sputum Model
por: Craddock, Vaughn D., et al.
Publicado: (2023)

The Role of Elastase in Corneal Epithelial Barrier Dysfunction Caused by Pseudomonas aeruginosa Exoproteins
por: Li, Ye, et al.
Publicado: (2021)

The role of secretory leukocyte proteinase inhibitor and elafin (elastase-specific inhibitor/skin-derived antileukoprotease) as alarm antiproteinases in inflammatory lung disease
por: Sallenave, Jean-Michel
Publicado: (2000)

Myeloperoxidase and eosinophil cationic protein in serum and sputum during antibiotic treatment in cystic fibrosis patients with Pseudomonas aeruginosa infection
por: Niggemann, B., et al.
Publicado: (1995)

Comparison of the sensitivity of culture, PCR and quantitative real-time PCR for the detection of Pseudomonas aeruginosa in sputum of cystic fibrosis patients
por: Deschaght, Pieter, et al.
Publicado: (2009)

Reduction in Pseudomonas aeruginosa sputum density during a cystic fibrosis pulmonary exacerbation does not predict clinical response
por: Lam, John C, et al.
Publicado: (2015)

Draft Genome Sequence of the Multidrug-Resistant Strain Pseudomonas aeruginosa PA291, Isolated from Cystic Fibrosis Sputum
por: Luong, Tiffany, et al.
Publicado: (2021)

Combination of Serologic Tests and Sputum Culture Results as the Best Diagnostic Method of Pseudomonas aeruginosa Infection in Cystic Fibrosis Patients
por: Khanbabaee, Ghamartaj, et al.
Publicado: (2023)

SARS-CoV-2 disrupts clinical research: the role of a rare disease-specific trial network
por: van Koningsbruggen-Rietschel, Silke, et al.
Publicado: (2020)

Design of a gold nanoprobe for the detection of Pseudomonas aeruginosa elastase gene (lasB)
por: Farhangi, Alireza, et al.
Publicado: (2020)

The Structures and Binding Modes of Small-Molecule Inhibitors of Pseudomonas aeruginosa Elastase LasB
por: Camberlein, Virgyl, et al.
Publicado: (2022)

Physiological levels of nitrate support anoxic growth by denitrification of Pseudomonas aeruginosa at growth rates reported in cystic fibrosis lungs and sputum
por: Line, Laura, et al.
Publicado: (2014)

Use of Artificial Sputum Medium to Test Antibiotic Efficacy Against Pseudomonas aeruginosa in Conditions More Relevant to the Cystic Fibrosis Lung
por: Kirchner, Sebastian, et al.
Publicado: (2012)

Draft Genome Sequences of Five Pseudomonas aeruginosa Clinical Strains Isolated from Sputum Samples from Cystic Fibrosis Patients
por: Couger, M. B., et al.
Publicado: (2016)

Multidrug-resistant Pseudomonas aeruginosa from sputum of patients with cystic fibrosis demonstrates a high rate of susceptibility to ceftazidime–avibactam
por: Atkin, Stan D, et al.
Publicado: (2018)

High throughput determination of the biofilm prevention concentration for Pseudomonas aeruginosa biofilms using a synthetic cystic fibrosis sputum medium
por: De Bleeckere, Amber, et al.
Publicado: (2023)

Protecting clinical trials in cystic fibrosis during the SARS-CoV-2 pandemic: risks and mitigation measures
por: van Koningsbruggen-Rietschel, Silke, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_kr0rs17vvoto95cjui4l64gtv3